Patent details

EP3256154 Title: PHARMACEUTICAL FORMULATION COMPRISING ANTIBODY

Basic Information

Publication number:
EP3256154
PCT Application Number:
EP2016052494
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP167032978
PCT Publication Number:
WO2016128318
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL FORMULATION COMPRISING ANTIBODY
French Title of Invention:
FORMULATION PHARMACEUTIQUE COMPRENANT DES ANTICORPS
German Title of Invention:
PHARMAZEUTISCHE FORMULIERUNG BEINHALTEND ANTIKÖRPER
SPC Number:

Dates

Filing date:
05/02/2016
Grant date:
02/10/2019
EP Publication Date:
20/12/2017
PCT Publication Date:
18/08/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/10/2019
EP B1 Publication Date:
02/10/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
05/02/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/12/2019
 
 

Name:
UCB Biopharma SRL
Address:
Allé de la Recherche 60, 1070 Brussels, Belgium (BE)

History of Owners

From:
25/09/2019
To:
06/12/2019

Name:
UCB Biopharma SPRL
Address:
60, Allée de la Recherche, 1070 Brussels, Belgium (BE)

Agent

Name:
UCB Propriété Intellectuelle c/o UCB Celltech
From:
20/12/2019
Address:
208 Bath Road, SL1 3WE, Slough, United Kingdom (GB)
To:

Inventor

1

Name:
BOONEN, Michael Joseph Edouard
Address:
Belgium (BE)

2

Name:
PEERBOOM, Claude
Address:
Belgium (BE)

Priority

Priority Number:
15154301
Priority Date:
09/02/2015
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 9/00; A61K 9/08; A61K 39/395; A61K 47/12; A61K 47/26; C07K 16/28; A61K 47/18;

Publication

European Patent Bulletin

1

Issue number:
201940
Publication date:
02/10/2019
Description:
Grant (B1)

2

Issue number:
202002
Publication date:
08/01/2020
Description:
Transfer of Rights

Annual Fees

Annual Fee Due Date:
02/03/2026
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
27/01/2025
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
23/12/2019 Outgoing Correspondence 1
20/12/2019 Power Of Attorney 4